Docquity partners with global pharma leader to support the continuing education of medical professionals across 7 countries in Asia
SINGAPORE, July 20, 2020 /PRNewswire/ -- Docquity, Southeast Asia's largest professional network of doctors, has partnered with Swiss research-based healthcare company Novartis to deliver bite-sized, continual learning, and education support to doctors across seven countries in Asia. Novartis will work with Docquity and will host scientific information for the doctors through the Docquity platform.
Docquity and Novartis started this partnership in Indonesia in 2019 and extended the relationship to the Philippines and Malaysia. With this latest partnership expansion announcement, Docquity and Novartis will be working closely in Thailand, Vietnam, Pakistan, and Bangladesh. Novartis will work with local medical societies and provide invitation codes to doctors to enable them to join the continuing medical education network.
The COVID-19 pandemic has changed the way many industries operate and has propelled the pace of digitization exponentially as communities across the world go virtual.
Novartis is leveraging the Docquity network to provide quality scientific and clinical engagement programs for doctors in the region to optimize patient care.
Upcoming Life Sciences Events
- August 2020
- ChinaBio® Partnering Forum 2020 Digital
- Biotechgate Digital Partnering Event
- September 2020
- Basel: Pharma-Biotech Product & Company Valuation